Sanofi Aktie
86,05
EUR
-1,92
EUR
-2,18
%
86,60
EUR
+0,05
EUR
+0,06
%
Kursziele der Sanofi-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 118,00 EUR | +36,26% | 12.06.2025 | |
| Jefferies & Company Inc. | 120,00 EUR | +38,57% | 05.06.2025 | |
| Bernstein Research | 124,00 EUR | +43,19% | 04.06.2025 | |
| Deutsche Bank AG | 100,00 EUR | +15,47% | 03.06.2025 | |
| UBS AG | 115,00 EUR | +32,79% | 02.06.2025 | |
| JP Morgan Chase & Co. | 110,00 EUR | +27,02% | 02.06.2025 | |
| DZ BANK | - | - | 25.04.2025 | |
| Goldman Sachs Group Inc. | 117,00 EUR | +35,10% | 25.04.2025 | |
| Barclays Capital | 125,00 EUR | +44,34% | 24.04.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | - |
| Bayer | 2 | 7 | 0 | 26,00 EUR | -5,27% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +26,99% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 3 | 0 | 9,96 EUR | +34,23% |
| GSK PLC Registered Shs | 1 | 6 | 1 | 16,30 GBP | +7,84% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 165,86 EUR | +44,48% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +152,46% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +2,67% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,00 USD | +18,17% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 116,12 EUR | +34,09% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |